Shilpa Medicare Limited (NSE:SHILPAMED) — Market Cap & Net Worth
Market Cap & Net Worth: Shilpa Medicare Limited (SHILPAMED)
Shilpa Medicare Limited (NSE:SHILPAMED) has a market capitalization of $1.29 Billion (Rs119.55 Billion) as of August 4, 2026. Listed on the NSE stock exchange, this India-based company holds position #7681 globally and #383 in its home market, demonstrating a 1.27% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Shilpa Medicare Limited's stock price Rs611.25 by its total outstanding shares 195581816 (195.58 Million). See SHILPAMED capex reinvestment rate to understand how much of operating cash flow is reinvested back into capital assets.
Shilpa Medicare Limited Market Cap History: 2015 to 2026
Shilpa Medicare Limited's market capitalization history from 2015 to 2026. Data shows growth from $1.04 Billion to $1.29 Billion (2.41% CAGR).
Index Memberships
Shilpa Medicare Limited is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NIFTY MICROCAP 250
NIFTYMICROCAP250
|
$150.62 Billion | 0.86% | #32 of 250 |
|
NIFTY TOTAL MARKET
NIFTYTOTALMKT
|
$3.26 Trillion | 0.04% | #325 of 750 |
Weight: Shilpa Medicare Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Shilpa Medicare Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Shilpa Medicare Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.05x
Shilpa Medicare Limited's market cap is 0.05 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.87x
Shilpa Medicare Limited's market cap is 0.87 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.44 Billion | $6.38 Billion | $1.08 Billion | 0.23x | 1.33x |
| 2017 | $1.29 Billion | $7.30 Billion | $1.08 Billion | 0.18x | 1.20x |
| 2018 | $806.26 Million | $7.49 Billion | $1.05 Billion | 0.11x | 0.77x |
| 2019 | $592.10 Million | $7.01 Billion | $1.12 Billion | 0.08x | 0.53x |
| 2020 | $947.93 Million | $8.99 Billion | $1.56 Billion | 0.11x | 0.61x |
| 2021 | $1.13 Billion | $9.00 Billion | $1.48 Billion | 0.13x | 0.76x |
| 2022 | $588.75 Million | $11.40 Billion | $606.62 Million | 0.05x | 0.97x |
| 2023 | $698.63 Million | $10.43 Billion | -$325.33 Million | 0.07x | N/A |
| 2024 | $1.72 Billion | $11.53 Billion | $318.74 Million | 0.15x | 5.41x |
| 2025 | $679.28 Million | $12.86 Billion | $782.93 Million | 0.05x | 0.87x |
Competitor Companies of SHILPAMED by Market Capitalization
Companies near Shilpa Medicare Limited in the global market cap rankings as of August 4, 2026.
Key companies related to Shilpa Medicare Limited by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #503 globally with a market cap of $52.60 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #528 globally with a market cap of $50.48 Billion USD ( CN¥344.98 Billion CNY).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #550 globally with a market cap of $48.78 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #619 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #503 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #528 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $50.48 Billion | CN¥54.08 |
| #550 | GALDERMA GROUP AG | NYSE:GALDY | $48.78 Billion | $43.60 |
| #619 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €14.80 |
Shilpa Medicare Limited Historical Marketcap From 2015 to 2026
Between 2015 and today, Shilpa Medicare Limited's market cap moved from $1.04 Billion to $ 1.29 Billion, with a yearly change of 2.41%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs1.29 Billion | +90.33% |
| 2025 | Rs679.28 Million | -60.62% |
| 2024 | Rs1.72 Billion | +146.90% |
| 2023 | Rs698.63 Million | +18.66% |
| 2022 | Rs588.75 Million | -47.83% |
| 2021 | Rs1.13 Billion | +19.06% |
| 2020 | Rs947.93 Million | +60.10% |
| 2019 | Rs592.10 Million | -26.56% |
| 2018 | Rs806.26 Million | -37.62% |
| 2017 | Rs1.29 Billion | -10.31% |
| 2016 | Rs1.44 Billion | +38.89% |
| 2015 | Rs1.04 Billion | -- |
End of Day Market Cap According to Different Sources
On Aug 3rd, 2026 the market cap of Shilpa Medicare Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.29 Billion USD |
| MoneyControl | $1.29 Billion USD |
| MarketWatch | $1.29 Billion USD |
| marketcap.company | $1.29 Billion USD |
| Reuters | $1.29 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Shilpa Medicare Limited
Shilpa Medicare Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, biosimilars, and contract development and manufacturing organisation in India, the United States, Europe, and internationally. The company offers various oncology and non-oncology APIs, such as anastrozole, acebrophylline, ambroxol hydrochloride, … Read more